en · de · es · fr · pt
thymosin-alpha-1-notes.peptides9000.com › Info › Molecular Background And Immune Action — Evidence Review

Molecular Background And Immune Action — Evidence Review

By Editorial Desk · published 2026-05-20 · last reviewed 2026-07-05 · Info

This is a working overview of Thymosin alpha 1, written for readers who want more than a one-paragraph summary but less than a textbook.

Reviewed 2026-07-05. Anything still debated is marked as such rather than presented as settled.

Molecular Background and Immune Action

Thymosin alpha 1 is a synthetic 28-amino-acid peptide first isolated in 1966 from thymosin fraction 5, a bovine thymus extract. Its chain begins with an acetylated serine residue and ends with asparagine. The native peptide carries a molecular mass near 3,108 daltons. Researchers classify it as an immunomodulatory agent rather than a hormone with a single endocrine target. Early work framed it as a thymus-derived factor that supports T-cell maturation. The synthetic form used in research and clinical products matches the natural sequence.

Immune signaling studies link thymosin alpha 1 to Toll-like receptor pathways, particularly TLR2 and TLR9, on dendritic cells and other antigen-presenting cells. Activation of these receptors promotes maturation of T cells and increases natural killer cell activity. The peptide shifts cytokine output toward a T helper 1 profile, raising interferon gamma and interleukin 2 while modulating interleukin 10. Whether these effects translate into clinical benefit for any specific disease remains a subject of debate. Reported outcomes vary across trials and populations.

Analytical Methods and Storage Stability

Quantifying thymosin alpha-1 in a sample usually relies on reverse-phase high-performance liquid chromatography. The peptide lacks strong chromophores, so detection often occurs at 214 nm, where the peptide backbone absorbs. Mass spectrometry provides confirmatory identification and can detect sequence variants or truncations. Immunoassays have been used in biological matrices, but they may cross-react with related fragments. For purity assessment, chromatographic peak area gives the main component percentage, while mass accuracy verifies molecular identity.

The lyophilized peptide is generally stable for extended periods when kept cold and dry. Once dissolved, aqueous solutions are less stable; hydrolysis, oxidation, and aggregation can degrade the material. Storage at -20 °C or lower slows these processes. Repeated freeze-thaw cycles are best avoided because they can promote aggregation. The exact shelf life depends on formulation, pH, and concentration, so stability studies are typically performed for each specific product.

Thymosin-alpha-1 at a glance

PropertyValueNotes
Molecular mass≈3,108 DaSynthetic 28-residue peptide
Amino acid count28N-terminal serine carries an acetyl group
AppearanceWhite to off-white powderLyophilized solid
Water solubilityFreely solubleDissolves in aqueous buffer
Common synonymsThymalfasin; Tα1Thymalfasin is the international nonproprietary name

Molecular Identity Of Thymosin Alpha-1

Thymosin alpha-1 is a synthetic peptide of 28 amino acids whose sequence matches the amino-terminal region of prothymosin alpha. The chain is acetylated at its first residue and contains one disulfide bridge between two cysteine residues, which folds the molecule into a compact loop. Its molecular formula, C129H215N33O55, corresponds to a monoisotopic mass of roughly 3,106 daltons. Material used in laboratories is made by solid-phase synthesis rather than isolated from animal tissue.

Early work on thymic extracts in the 1960s described a heat-stable acidic fraction containing many polypeptides. Separation of that mixture yielded individual components, and thymosin alpha-1 was named as one of them on the basis of assays for T-cell activity. The first preparations came from calf thymus, while subsequent research and clinical material has been chemically synthesized. Nomenclature in older papers is inconsistent, and the same peptide sometimes appears under different designations, which complicates literature searches.

Related pages on this site

免疫调节机制与信号

胸腺素α1对免疫系统的影响涉及多种细胞类型。研究表明,它可促进未成熟T细胞向成熟T细胞分化,并增强T细胞对抗原刺激的增殖反应。树突状细胞在Tα1存在下表达更高水平的共刺激分子,从而更有效地呈递抗原。此外,自然杀伤细胞的活性也观察到上升。这些效应并非直接杀伤病原体,而是调节宿主免疫应答的强度与方向。

在信号层面,Tα1可能通过Toll样受体等模式识别受体发挥作用。部分实验显示,它能激活髓样分化因子88依赖的通路,进而促进核因子κB进入细胞核。这导致白细胞介素2、干扰素γ和白细胞介素12等细胞因子的转录增加。这些细胞因子偏向辅助性T细胞1型应答,有助于细胞免疫。然而,具体受体和结合位点尚未完全确定,不同实验模型的结果存在差异。

Notes from published material

The two main areas of research were the action of proteolytic enzymes and the chemical (as opposed to biological) synthesis of peptides (the substrates used to explore the enzymatic reactions). Members of Fruton's lab studied cathepsin C and several other peptidases, as well as proteinases that catalyzed transpeptidation, which was thought (and ultimately confirmed) to be part of the biosynthesis of proteins. Rather than leading a team effort focused on a small number of high-priority problems, Fruton allowed members of his laboratory to choose their own problems (usually within the broad bounds of protein synthesis and proteinases). Ph.D. students and postdoctoral researchers who worked in Fruton's lab include: Mary Ellen Jones, Melvin Fried, Hannelore Würz, Peter Heinrich, Karen Nilsson, Bob Metrione, Yoshihiro Okuda, George Taborsky, Christine Zioudrou, Maxine Singer, Louis Cohen, Frederick Newth, John Thanassi, Charles Drey, Derek George Smyth, Atsuo Nagamatsu, and Milton Winitz. A number of prominent biochemists from outside Yale also spent time in Fruton's biochemistry department during his tenure as chair, including: Harry Kroll, Rosabelle McManus, John Clark Lewis, Herbert Gutfreund, Max Gruber, Frank Hird, Vernon Ingram, Hans Kornberg, Dimitrios Theodoropoulos, and Hans Tuppy. In 1953, Fruton and Simmonds completed the textbook General Biochemistry, which became one of the most influential textbooks for a generation of biochemistry students. They produced a second edition in 1958.

==== Other beverages ==== Maté is a drink popular in many parts of South America. Its preparation consists of filling a gourd with the leaves of the South American holly yerba mate, pouring hot but not boiling water over the leaves, and drinking with a straw, the bombilla, which acts as a filter so as to draw only the liquid and not the yerba leaves. Guaraná is a soft drink originating in Brazil made from the seeds of the Guaraná fruit. The leaves of Ilex guayusa, the Ecuadorian holly tree, are placed in boiling water to make a guayusa tea. The leaves of Ilex vomitoria, the yaupon holly tree, are placed in boiling water to make a yaupon tea. Commercially prepared coffee-flavoured milk beverages are popular in Australia. Examples include Oak's Ice Coffee and Farmers Union Iced Coffee. The amount of caffeine in these beverages can vary widely. Caffeine concentrations can differ significantly from the manufacturer's claims.

=== C1q chains A, B and C === C1q is composed of 18 polypeptide chains: six A-chains, six B-chains, and six C-chains. Each chain contains a collagen-like region located near the N terminus and a C-terminal globular region. The A-, B-, and C-chains are arranged in the order A-C-B on chromosome 1.

Sources: en.wikipedia.org

Further detail

=== Finance === According to Nicolas Firzli, director of the World Pensions & Investments Forum, it may be too early to see the emergence of highly innovative AI-informed financial products and services. He argues that "the deployment of AI tools will simply further automatise things: destroying tens of thousands of jobs in banking, financial planning, and pension advice in the process, but I'm not sure it will unleash a new wave of [e.g., sophisticated] pension innovation."

Shortly after the start of the crisis, the Danish Realm began rapidly expanding its military capabilities in the Arctic. On 27 January 2025, its governments agreed to the First Agreement on the Arctic and North Atlantic, which invested a total of kr. 14.6 billion (US$2.05 billion) into warning systems in the Faroe Islands and Greenland, new naval vessels, drone warfare training, a new radiation monitoring station in East Greenland, upgrades to the Joint Arctic Command in Nuuk and intelligence, satellite surveillance, two new coastal radars, and Arctic basic military training in Kangerlussuaq. This was followed by the Second Agreement on 10 October 2025, providing upgrades worth kr. 27.4 billion (US$4.26 billion) for improvements of what was presented in the First Agreement, alongside upgrades to Kangerlussuaq Airport, a new specialised Arctic unit under the Jaeger Corps of the Special Operations Command that could operate anywhere in Greenland, establishment of radar capability in East Greenland, establishment of a Greenlandic reconnaissance Unit, and the construction of a new undersea cable connecting Greenland to mainland Denmark. In summer 2025, the Greenlandic government and the Danish Defence both announced that Greenland would have increased military presence by September, as part of Operation Arctic Light. On 18 August 2025, the Ministry of Justice allocated a package worth more than kr. 850 million to their operations in Greenland and the Faroe Islands.

== Effect on animals == Possible effects on animals are endocrine disruption, reproductive and immune dysfunction and cancer. A remarkable phenomenon that has been demonstrated in numerous animal studies is that repeated exposure to organophosphates causes the mammals to be less susceptible to the toxic effects of the AChE inhibitors, even though cholinesterase activities are not normal. This phenomenon is caused by the excess of agonists (ACh) within the synapse, ultimately leading to a down-regulation of cholinergic receptors. Consequently, a given concentration of ACh within the synapse causes fewer receptors to be available, which then causes a lower response. Studies have shown that the AChEs in fish brains are more prone to organophosphates than amphibian brains. This can be explained by the affinity for AzM and rate of phosphorylation of the enzymes. Frog brain AChE has for example a lower affinity for AzM and a slower rate of phosphorylation than fish brain AChE. The effects on amphibians are “reduced size, notochord bending, abnormal pigmentation, defective gut and gills, swimming in circles, body shortening, and impaired growth”. In sea urchins, specifically the Paracentrotus lividus, AzM modifies the cytoskeleton assembly at high concentrations and can alter the deposition of the skeleton of the larva at low concentrations. In mice, AzM causes weight loss, inhibits brain cholinesterase (ChE) and lowers the food consumption of the mice. A decrease of 45-50% of brain ChE is lethal in mice. Also in earthworms and rats, AzM decreases AChE activity.

Sources: en.wikipedia.org

Supporting material

The decay of 40K in Earth's mantle ranks third, after 232Th and 238U, in the list of sources of radiogenic heat. Less is known about the amount of radiogenic sources in Earth's outer and inner core, which lie below the mantle. It has been proposed, though, that significant core radioactivity (1–2 TW) may be caused by high levels of U, Th and K. Potassium-40 is the largest source of natural radioactivity in animals including humans. A 70 kg human body contains about 140 g (or 126 g) of potassium, hence about 140g × 0.0117% * (39.96/39.10) ≈ 16.7 mg of 40K; whose decay produces about 3,850 to 4,300 disintegrations per second (becquerel) continuously throughout the life of an adult person (and proportionally less in children). The normal potassium-40 concentration in the human body is equivalent to 55 Bq per kilogram, corresponding to an effective dose of 0.2 millisievert per year throughout the body. This is the largest source of internal radiation, followed by 0.12 mSv per year from the nuclides in the uranium and thorium decay series, and just 12 microsieverts per year from carbon-14.

==== United Kingdom ==== Insulin, and all other medications, are supplied free of charge to people who use it to manage their diabetes by the National Health Services of the countries of the United Kingdom.

== Industry == In 2020, the American market for dietary supplements was valued at $140.3 billion, with the economic impact in the United States for 2016 estimated at $122 billion, including employment wages and taxes. A 2020 analysis projected that the global market for vitamins and dietary supplement products would reach $196.6 billion by 2028, where the growth in market size is largely attributed to recent technological advancements in product manufacturing, increased demand for products advertised as healthy, increased product availability, and population aging.

Sources: en.wikipedia.org

Frequently asked questions

What is thymosin alpha 1 made of?

It is a chain of 28 amino acids, with an acetyl group attached to the first serine residue. The synthetic version replicates this sequence. Its molecular mass is about 3,108 daltons.

Is thymosin alpha 1 a hormone?

It is usually described as an immunomodulatory peptide rather than a classic hormone. It acts on immune cells through receptor pathways. No single endocrine organ target defines its function.

Where is thymosin alpha 1 approved?

Several countries, including Italy and China, allow it for specific indications. The FDA has not approved it as a drug in the United States. Availability depends on local regulation.

How is thymosin alpha-1 measured in a laboratory?

Reverse-phase HPLC with ultraviolet detection at 214 nm is common. Mass spectrometry is used to confirm molecular identity and detect modifications. Immunoassays exist but may not distinguish the intact peptide from fragments.

Network